Drugmaker settles EpiPen antitrust litigation for $264M | The Hill: Healthcare Policy

U.S. health care company Viatris, formerly known as Myland, on Monday announced it had agreed to pay $264 million to settle a class-action lawsuit over the pricing of EpiPens.The agreement, which must still be approved by the court, would seek...